• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

规划与分析适应性成组序贯生存试验

Planning and analyzing adaptive group sequential survival trials.

作者信息

Wassmer Gernot

机构信息

Institute for Medical Statistics, Informatics, and Epidemiology, University of Cologne, Cologne, Germany.

出版信息

Biom J. 2006 Aug;48(4):714-29. doi: 10.1002/bimj.200510190.

DOI:10.1002/bimj.200510190
PMID:16972724
Abstract

The use of adaptive methods has experienced increasing interest in the current literature on group sequential designs. Group sequential analysis in survival trials usually apply the error spending function approach due to the unpredictable amount of information available in an interim analysis. An alternative way is to apply adaptive methods where additionally the maximum amount of information and other designing parameters can be changed based on the information available at the interim stage. In this paper, it is shown how the inverse normal method can be used within a survival design using the log-rank test for comparing two survival functions. This method allows for many kinds of design modifications. In case of no modifications, the inverse normal method coincides with the commonly used analysis strategy. It is straightforward to specify effect estimates. Confidence intervals for the hazard ratio that can be calculated at each stage of the trial and intervals that can only be computed by the end of the trial are proposed. The latter also enables the calculation of median unbiased estimates. Overall p-values can be defined analogously. Properties of the analyses techniques are investigated and compared with alternative approaches. It is shown that the proposed analysis technique might help to rescue an underpowered study and opens the way to other types of changes in design. The proposed technique is implemented in the software ADDPLAN Adaptive Design, Plans and Analyses (http://www.addplan.com).

摘要

在当前关于成组序贯设计的文献中,自适应方法越来越受到关注。生存试验中的成组序贯分析通常采用误差消耗函数方法,因为中期分析中可用信息的数量不可预测。另一种方法是应用自适应方法,在这种方法中,还可以根据中期阶段获得的信息改变最大信息量和其他设计参数。本文展示了如何在生存设计中使用逆正态方法,利用对数秩检验来比较两个生存函数。这种方法允许进行多种设计修改。在不进行修改的情况下,逆正态方法与常用的分析策略一致。指定效应估计很简单。提出了在试验的每个阶段都可以计算的风险比置信区间以及只能在试验结束时计算的区间。后者还能够计算中位数无偏估计。总体p值可以类似地定义。研究了分析技术的性质,并与其他方法进行了比较。结果表明,所提出的分析技术可能有助于挽救一项效能不足的研究,并为其他类型的设计变更开辟道路。所提出的技术在软件ADDPLAN自适应设计、计划与分析(http://www.addplan.com)中得以实现。

相似文献

1
Planning and analyzing adaptive group sequential survival trials.规划与分析适应性成组序贯生存试验
Biom J. 2006 Aug;48(4):714-29. doi: 10.1002/bimj.200510190.
2
Survival endpoints and adaptive designs.生存终点与适应性设计。
Biom J. 2006 Aug;48(4):730-1. doi: 10.1002/bimj.200610245.
3
On efficient two-stage adaptive designs for clinical trials with sample size adjustment.关于具有样本量调整的临床试验的高效两阶段自适应设计。
J Biopharm Stat. 2012;22(4):617-40. doi: 10.1080/10543406.2012.678226.
4
On adaptive error spending approach for group sequential trials with random information levels.关于具有随机信息水平的成组序贯试验的自适应误差消耗方法。
J Biopharm Stat. 2012;22(4):687-99. doi: 10.1080/10543406.2012.678232.
5
Flexible designs by adaptive plans of generalized Pocock- and O'Brien-Fleming-type and by self-designing clinical trials.通过广义Pocock型和O'Brien-Fleming型适应性计划以及自行设计的临床试验实现的灵活设计。
Biom J. 2006 Aug;48(4):521-36. doi: 10.1002/bimj.200510212.
6
Repeated confidence intervals for adaptive group sequential trials.适应性成组序贯试验的重复置信区间
Stat Med. 2007 Dec 30;26(30):5422-33. doi: 10.1002/sim.3062.
7
An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.对具有预先指定样本量修改规则的适应性临床试验设计的推断程序的评估。
Biometrics. 2014 Sep;70(3):556-67. doi: 10.1111/biom.12168. Epub 2014 Apr 25.
8
A free gift: an adaptive strategy in a single-arm trial using an exact test through the binomial distribution.免费赠品:在单臂试验中通过二项分布的精确检验采用的一种适应性策略。
J Biopharm Stat. 2012;22(6):1127-36. doi: 10.1080/10543406.2011.574327.
9
A unified method for monitoring and analysing controlled trials.一种监测和分析对照试验的统一方法。
Stat Med. 1994 Sep 30;13(18):1815-26. doi: 10.1002/sim.4780131804.
10
Implementing type I & type II error spending for two-sided group sequential designs.在双侧成组序贯设计中实施I型和II型错误消耗。
Contemp Clin Trials. 2008 May;29(3):351-8. doi: 10.1016/j.cct.2007.09.002. Epub 2007 Sep 21.

引用本文的文献

1
Confidence Intervals for Adaptive Trial Designs I: A Methodological Review.适应性试验设计的置信区间I:方法学综述
Stat Med. 2025 Aug;44(18-19):e70174. doi: 10.1002/sim.70174.
2
Adaptive Weight Selection for Time-To-Event Data Under Non-Proportional Hazards.非比例风险下生存时间数据的自适应权重选择
Stat Med. 2025 Mar 15;44(6):e70045. doi: 10.1002/sim.70045.
3
Point estimation for adaptive trial designs I: A methodological review.自适应试验设计的点估计 I:方法学综述。
Stat Med. 2023 Jan 30;42(2):122-145. doi: 10.1002/sim.9605. Epub 2022 Nov 30.
4
Quantifying treatment differences in confirmatory trials under non-proportional hazards.在非比例风险下的验证性试验中量化治疗差异。
J Appl Stat. 2020 Sep 3;49(2):466-484. doi: 10.1080/02664763.2020.1815673. eCollection 2022.
5
Adaptive group sequential survival comparisons based on log-rank and pointwise test statistics.基于对数秩检验和逐点检验统计量的自适应分组序贯生存比较。
Stat Methods Med Res. 2021 Dec;30(12):2562-2581. doi: 10.1177/09622802211043262. Epub 2021 Oct 12.
6
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial.布加替尼与其他第二代间变性淋巴瘤激酶抑制剂作为深度表型分析的间变性淋巴瘤激酶阳性非小细胞肺癌的初始治疗比较:ABP 试验研究方案。
BMC Cancer. 2021 Jun 28;21(1):743. doi: 10.1186/s12885-021-08460-w.
7
Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection.具有事件发生时间数据和生物标志物驱动的亚组选择的两阶段自适应设计中的点估计和区间估计。
Stat Med. 2020 Aug 30;39(19):2568-2586. doi: 10.1002/sim.8557. Epub 2020 May 3.
8
Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R.自适应无缝临床试验,使用早期结果进行治疗或亚组选择:方法、模拟模型及其在 R 中的实现。
Biom J. 2020 Sep;62(5):1264-1283. doi: 10.1002/bimj.201900020. Epub 2020 Mar 2.
9
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.高剂量化疗与标准化疗和肺放疗联合治疗伴肺转移尤文肉瘤的疗效比较:来自欧洲尤文肿瘤国家协作组 99 试验和 EWING2008 试验的结果。
J Clin Oncol. 2019 Dec 1;37(34):3192-3202. doi: 10.1200/JCO.19.00915. Epub 2019 Sep 25.
10
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.依他佐辛鼻喷剂联合口服抗抑郁药治疗治疗抵抗性抑郁症患者预防复发的疗效:一项随机临床试验。
JAMA Psychiatry. 2019 Sep 1;76(9):893-903. doi: 10.1001/jamapsychiatry.2019.1189.